TODAY’S NEWS
How to do dumb insider trading – a lesson.
Experimental Plavix competitor Brilinta showing improved efficacy in ACS stent patients.
Enbrel competitor Stelera shows greater efficacy in psoriasis treatment.
Obesity leveling off in U.S., but Diabetes is killing the economy.
RECOMMENDED
Management development. From full curriculum planning to workshops to targeted courses, we have the providers you need in our vendor/partner network. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
PLUS
JUST FOR FUN
———-
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
Connect with Steve Woodruff
Leave a Reply